Stable growth hormone compounds

Details for Australian Patent Application No. 2011208620 (hide)

Owner Novo Nordisk Health Care AG

Inventors Demuth, Helle; Schiodt, Christine Bruun Schiodt; Norskov-Lauritsen, Leif; Chen, Jianhe; Thygesen, Peter

Agent Shelston IP

Pub. Number AU-A-2011208620

PCT Pub. Number WO2011/089250

Priority PCT/ CN2010/001120 23.07.10 CN; 61/378,602 31.08.10 US; 61/297,305 22.01.10 US; 10151405.7 22.01.10 EP

Filing date 24 January 2011

Wipo publication date 28 July 2011

International Classifications

C07K 14/61 Peptides having more than 20 amino acids

A61K 38/27 Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 5/00 Drugs for disorders of the endocrine system

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/089250 Priority application(s): WO2011/089250

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011208621-Fuel management system and method

2011208616-Drive assembly for a drug delivery device and drug delivery device